188
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2

, , , , , , & show all
Pages 1475-1492 | Published online: 08 Jun 2018

Figures & data

Figure 1 Procedures before initiating an LAI and partnering with patients.

Notes: (A) Appropriate treatment setting for initiating treatment with an LAI (rating scale: 1, not appropriate at all; 9, extremely appropriate), (B) important steps in initiating treatment with an LAI (rating scale: 1, not important at all; 9, extremely important), and (C) importance of discussing potential benefits of LAIs in motivating patients to use an LAI (rating scale: 1, not important at all; 9, extremely important). An asterisk in a bar represents an option that received the highest ranking of 9 by ≥50% of respondents. Horizontal bars represent CIs. Open bars indicate no consensus; shaded bars indicate consensus (dark shading: first line; medium shading: second line; light shading: third line). High second line: CI bar crosses the boundary with first line.
Abbreviation: LAI, long-acting injectable antipsychotic.
Figure 1 Procedures before initiating an LAI and partnering with patients.
Figure 1 Procedures before initiating an LAI and partnering with patients.

Table 1 Factors to consider in selecting an LAI

Figure 2 Optimizing maintenance treatment and supporting LAI adherence.

Notes: (A) Optimal interval between injections (rating scale: 1, extremely inappropriate; 9, extremely appropriate) and (B) effectiveness of strategies during maintenance treatment with an LAI to optimize the patient’s adherence to appointments for LAI administration (rating scale: 1, likely to be ineffective; 9, likely to be effective). Horizontal bars represent CIs. Open bars indicate no consensus; shaded bars indicate consensus (dark shading: first line; medium shading: second line; light shading: third line). High second line: CI bar crosses the boundary with first line.
Abbreviation: LAI, long-acting injectable antipsychotic.
Figure 2 Optimizing maintenance treatment and supporting LAI adherence.

Table 2 Strategies for an inadequate response to an LAI in patients with schizophrenia/schizoaffective or bipolar disorder

Table 3 Summary of first-line recommendations for initiating and maintaining treatment with an LAI

Table S1 Frequency of medical monitoring during and after the first 6 months of treatment with LAIs